ClinicalTrials.Gov Could Monitor Reimbursement Impact On Trials – AHRQ
This article was originally published in The Gray Sheet
Executive Summary
Government health care agencies could use ClinicalTrials.gov to learn how third-party payment impacts enrollment in clinical trials, Duke Evidence-Based Practice Center researchers suggest in a new white paper commissioned by the Agency for Healthcare Research and Quality (AHRQ)